7Baggers

Abbott Laboratories Quarterly Balance Sheets Chart

Quarterly
 | 
Annual
 
 Goodwill  
 Cash and Cash Eq  
 Long-Term Debt  
20200930 20201231 20210331 20210630 20210930 20211231 20220331 20220630 20220930 20221231 20230331 20230630 20230930 20231231 20240331 20240630 20240930 20241231 20250331 20250630 03.426.8410.2713.6917.1120.5323.95Billion

Abbott Laboratories Quarterly Balance Sheets Table

Quarterly
 | 
Annual
 
Unit: USD2025-06-30 2025-03-31 2024-12-31 2024-09-30 2024-06-30 2024-03-31 2023-12-31 2023-09-30 2023-06-30 2023-03-31 2022-12-31 2022-09-30 2022-06-30 2022-03-31 2021-12-31 2021-09-30 2021-06-30 2021-03-31 2020-12-31 2020-09-30 2020-06-30 2020-03-31 2019-12-31 2019-09-30 2019-06-30 2019-03-31 2018-09-30 2018-06-30 2018-03-31 2017-09-30 2017-06-30 2017-03-31 2016-09-30 2016-06-30 2016-03-31 2015-09-30 2015-06-30 2015-03-31 2014-09-30 2014-06-30 2014-03-31 2010-09-30 2010-06-30 2010-03-31 
                                              
  assets                                            
  current assets:                                            
  cash and cash equivalents6,951,000,000 6,532,000,000 7,616,000,000 7,558,000,000 6,987,000,000 6,284,000,000 6,896,000,000 6,709,000,000 7,835,000,000 9,161,000,000 9,882,000,000 9,594,000,000 8,937,000,000 7,675,000,000 9,799,000,000 9,302,000,000 8,658,000,000 8,054,000,000 6,838,000,000 4,480,000,000 4,763,000,000 3,377,000,000 3,860,000,000 4,091,000,000 3,137,000,000 3,022,000,000 7,369,000,000 3,065,000,000 3,857,000,000 11,012,000,000 9,675,000,000 8,706,000,000 2,500,000,000 2,578,000,000 3,334,000,000 3,132,000,000 4,048,000,000 3,226,000,000 3,613,000,000 3,570,000,000 2,060,000,000 3,818,145,000 4,321,702,000 1,566,820,000 
  short-term investments331,000,000 312,000,000  230,000,000 232,000,000 367,000,000  338,000,000 320,000,000 371,000,000  313,000,000 353,000,000 483,000,000  390,000,000 286,000,000 318,000,000  251,000,000 274,000,000 291,000,000  244,000,000 239,000,000 239,000,000 181,000,000 199,000,000 185,000,000 187,000,000 160,000,000 154,000,000 2,007,000,000 1,860,000,000 623,000,000 3,007,000,000 7,129,000,000 6,623,000,000       
  trade receivables, less allowances of 471 in 2025 and 439 in 20247,972,000,000                                            
  inventories:                                            
  finished products4,319,000,000 4,063,000,000 3,700,000,000 4,173,000,000 4,060,000,000 4,063,000,000 3,946,000,000 3,847,000,000 4,004,000,000 3,944,000,000 3,805,000,000 3,407,000,000 3,570,000,000 3,470,000,000 3,081,000,000 3,048,000,000 3,118,000,000 3,219,000,000 3,030,000,000 3,173,000,000 3,240,000,000 2,873,000,000 2,784,000,000 2,846,000,000 2,786,000,000 2,641,000,000 2,340,000,000 2,264,000,000 2,424,000,000 2,273,000,000 2,355,000,000 2,704,000,000 1,763,000,000 1,865,000,000 1,980,000,000 1,810,000,000 1,869,000,000 1,780,000,000 1,873,000,000 1,920,000,000 1,921,000,000 2,025,154,000 1,933,692,000 2,138,884,000 
  work in process962,000,000 890,000,000 840,000,000 877,000,000 880,000,000 881,000,000 807,000,000 888,000,000 845,000,000 805,000,000 680,000,000 726,000,000 710,000,000 695,000,000 694,000,000 710,000,000 796,000,000 773,000,000 712,000,000 721,000,000 675,000,000 615,000,000 560,000,000 584,000,000 584,000,000 536,000,000 561,000,000 563,000,000 536,000,000 456,000,000 450,000,000 509,000,000 326,000,000 340,000,000 306,000,000 289,000,000 303,000,000 287,000,000 290,000,000 339,000,000 322,000,000 705,676,000 724,835,000 746,890,000 
  materials1,673,000,000 1,686,000,000 1,654,000,000 1,763,000,000 1,874,000,000 1,883,000,000 1,817,000,000 1,915,000,000 2,022,000,000 1,924,000,000 1,688,000,000 1,601,000,000 1,619,000,000 1,526,000,000 1,382,000,000 1,503,000,000 1,525,000,000 1,395,000,000 1,270,000,000 1,258,000,000 1,287,000,000 1,080,000,000 972,000,000 962,000,000 982,000,000 908,000,000 880,000,000 887,000,000 866,000,000 754,000,000 798,000,000 782,000,000 524,000,000 608,000,000 500,000,000 534,000,000 563,000,000 556,000,000 533,000,000 564,000,000 532,000,000 577,928,000 510,114,000 525,147,000 
  total inventories6,954,000,000 6,639,000,000 6,194,000,000 6,813,000,000 6,814,000,000 6,827,000,000 6,570,000,000 6,650,000,000 6,871,000,000 6,673,000,000 6,173,000,000 5,734,000,000 5,899,000,000 5,691,000,000 5,157,000,000 5,261,000,000 5,439,000,000 5,387,000,000 5,012,000,000 5,152,000,000 5,202,000,000 4,568,000,000 4,316,000,000 4,392,000,000 4,352,000,000 4,085,000,000 3,781,000,000 3,714,000,000 3,826,000,000 3,483,000,000 3,603,000,000 3,995,000,000 2,613,000,000 2,813,000,000 2,786,000,000 2,633,000,000 2,735,000,000 2,623,000,000 2,696,000,000 2,823,000,000 2,775,000,000 3,308,758,000 3,168,641,000 3,410,921,000 
  prepaid expenses and other receivables2,260,000,000 2,343,000,000  2,150,000,000 2,232,000,000 2,293,000,000  2,468,000,000 2,307,000,000 2,152,000,000  2,796,000,000 2,568,000,000 2,401,000,000  2,134,000,000 2,131,000,000 1,962,000,000  1,858,000,000 1,842,000,000 1,970,000,000  1,942,000,000 1,919,000,000 1,718,000,000 1,582,000,000 1,935,000,000 1,720,000,000 1,895,000,000 1,912,000,000 1,964,000,000 1,986,000,000 2,104,000,000 2,157,000,000          
  total current assets24,468,000,000 23,153,000,000 23,656,000,000 23,802,000,000 23,119,000,000 22,376,000,000 22,670,000,000 22,664,000,000 23,505,000,000 24,377,000,000 25,224,000,000 24,845,000,000 24,956,000,000 23,429,000,000 24,239,000,000 23,492,000,000 22,627,000,000 21,817,000,000 20,441,000,000 17,390,000,000 17,221,000,000 15,498,000,000 15,667,000,000 16,119,000,000 15,195,000,000 14,409,000,000 18,196,000,000 14,122,000,000 14,964,000,000 21,377,000,000 19,983,000,000 19,329,000,000 12,978,000,000 12,988,000,000 12,406,000,000 15,894,000,000 21,131,000,000 19,985,000,000 16,464,000,000 18,258,000,000 17,931,000,000 19,447,420,000 19,915,307,000 17,690,678,000 
  investments958,000,000 907,000,000 886,000,000 912,000,000 877,000,000 818,000,000 799,000,000 788,000,000 799,000,000 776,000,000 766,000,000 764,000,000 734,000,000 763,000,000 816,000,000 812,000,000 805,000,000 832,000,000 821,000,000 803,000,000 776,000,000 790,000,000 883,000,000 874,000,000 851,000,000 867,000,000 971,000,000 940,000,000 913,000,000 1,386,000,000 1,545,000,000 1,756,000,000 2,997,000,000 3,339,000,000 3,552,000,000 3,055,000,000 243,000,000 244,000,000 221,000,000 130,000,000 122,000,000 255,153,000 251,240,000 1,120,483,000 
  property and equipment, at cost24,472,000,000 23,418,000,000  22,857,000,000 22,061,000,000 22,055,000,000  21,111,000,000 20,926,000,000 20,605,000,000  19,306,000,000 19,458,000,000 19,521,000,000  19,182,000,000 19,074,000,000 18,697,000,000  17,972,000,000 17,374,000,000 16,707,000,000  16,343,000,000 16,331,000,000 15,905,000,000 15,520,000,000 15,309,000,000 15,556,000,000 14,698,000,000 14,476,000,000 14,172,000,000 12,452,000,000 12,712,000,000 12,709,000,000 12,528,000,000 12,433,000,000 12,251,000,000 12,694,000,000 13,096,000,000 13,005,000,000 17,259,216,000 16,856,968,000 16,803,187,000 
  less: accumulated depreciation and amortization13,077,000,000 12,486,000,000 12,082,000,000 12,236,000,000 11,828,000,000 11,948,000,000 11,779,000,000 11,559,000,000 11,477,000,000 11,323,000,000 11,050,000,000 10,617,000,000 10,640,000,000 10,613,000,000 10,405,000,000 10,351,000,000 10,258,000,000 9,865,000,000 9,764,000,000 9,352,000,000 9,031,000,000 8,800,000,000 8,761,000,000 8,518,000,000 8,506,000,000 8,279,000,000 8,072,000,000 7,877,000,000 7,897,000,000 7,479,000,000 7,190,000,000 6,907,000,000 6,718,000,000 6,886,000,000 6,873,000,000 6,731,000,000 6,695,000,000 6,552,000,000 6,822,000,000 7,161,000,000 7,057,000,000 9,319,429,000 8,981,360,000 8,743,073,000 
  net property and equipment11,395,000,000 10,932,000,000 10,658,000,000 10,621,000,000 10,233,000,000 10,107,000,000 10,154,000,000 9,552,000,000 9,449,000,000 9,282,000,000 9,162,000,000 8,689,000,000 8,818,000,000 8,908,000,000 8,959,000,000 8,831,000,000 8,816,000,000 8,832,000,000 9,029,000,000 8,620,000,000 8,343,000,000 7,907,000,000 8,038,000,000 7,825,000,000 7,825,000,000 7,626,000,000 7,448,000,000 7,432,000,000 7,659,000,000 7,219,000,000 7,286,000,000 7,265,000,000 5,734,000,000 5,826,000,000 5,836,000,000 5,797,000,000 5,738,000,000 5,699,000,000 5,872,000,000 5,935,000,000 5,948,000,000 7,939,787,000 7,875,608,000 8,060,114,000 
  intangible assets, net of amortization5,920,000,000 6,261,000,000 6,647,000,000 7,352,000,000 7,827,000,000 8,296,000,000 8,815,000,000 9,282,000,000 9,834,000,000 10,006,000,000 10,454,000,000 10,850,000,000 11,592,000,000 12,225,000,000 12,739,000,000 13,312,000,000 13,681,000,000 14,181,000,000 14,784,000,000 15,208,000,000 15,783,000,000 16,265,000,000 17,025,000,000 17,465,000,000 18,091,000,000 18,472,000,000 19,477,000,000 19,951,000,000 20,943,000,000 18,578,000,000 18,653,000,000 19,405,000,000 4,674,000,000 5,311,000,000 5,458,000,000 5,844,000,000 5,785,000,000 5,979,000,000 6,094,000,000 5,428,000,000 5,613,000,000 12,646,677,000 10,266,399,000 10,663,369,000 
  goodwill23,952,000,000 23,359,000,000 23,108,000,000 23,658,000,000 23,308,000,000 23,383,000,000 23,679,000,000 23,277,000,000 23,258,000,000 22,927,000,000 22,799,000,000 22,284,000,000 22,744,000,000 23,179,000,000 23,231,000,000 23,299,000,000 23,485,000,000 23,384,000,000 23,744,000,000 23,338,000,000 23,082,000,000 22,927,000,000 23,195,000,000 23,046,000,000 23,329,000,000 23,209,000,000 23,416,000,000 23,844,000,000 24,227,000,000 22,066,000,000 22,132,000,000 21,353,000,000 7,812,000,000 9,752,000,000 9,775,000,000 9,750,000,000 9,896,000,000 9,855,000,000 10,048,000,000 9,751,000,000 9,781,000,000 15,807,536,000 14,218,098,000 15,007,686,000 
  deferred income taxes and other assets17,306,000,000 16,836,000,000 16,459,000,000 8,011,000,000 7,653,000,000 7,487,000,000 7,097,000,000 6,527,000,000 6,509,000,000 6,426,000,000 6,033,000,000 5,369,000,000 5,358,000,000 5,503,000,000 5,212,000,000 4,049,000,000 3,855,000,000 3,739,000,000 3,729,000,000 3,684,000,000 3,571,000,000 3,390,000,000 3,079,000,000 3,210,000,000 3,136,000,000 3,027,000,000 2,110,000,000 2,005,000,000 2,082,000,000 1,565,000,000 1,552,000,000 1,779,000,000 2,523,000,000 2,613,000,000 2,608,000,000 1,383,000,000 1,330,000,000 1,330,000,000 1,772,000,000 1,921,000,000 2,214,000,000 1,277,047,000 854,750,000 816,292,000 
  liabilities and shareholders’ investment                                            
  current liabilities:                                            
  trade accounts payable4,306,000,000 4,214,000,000 4,195,000,000 4,034,000,000 4,125,000,000 4,178,000,000 4,295,000,000 3,961,000,000 4,211,000,000 4,167,000,000 4,607,000,000 4,133,000,000 4,493,000,000 4,757,000,000 4,408,000,000 4,017,000,000 4,017,000,000 4,066,000,000 3,946,000,000 3,189,000,000 3,335,000,000 3,181,000,000 3,252,000,000 3,029,000,000 3,222,000,000 3,045,000,000 2,730,000,000 2,503,000,000 2,476,000,000 1,858,000,000 1,667,000,000 1,481,000,000 1,051,000,000 1,153,000,000 1,053,000,000 1,007,000,000 1,000,000,000 1,012,000,000 965,000,000 1,062,000,000 1,074,000,000 1,531,720,000 1,615,606,000 1,663,523,000 
  salaries, wages and commissions1,550,000,000 1,167,000,000 1,701,000,000 1,618,000,000 1,389,000,000 1,092,000,000 1,597,000,000 1,479,000,000 1,362,000,000 1,098,000,000 1,556,000,000 1,426,000,000 1,315,000,000 1,147,000,000 1,625,000,000 1,470,000,000 1,248,000,000 1,117,000,000 1,416,000,000 1,439,000,000 1,121,000,000 949,000,000 1,237,000,000 1,258,000,000 1,018,000,000 886,000,000 1,241,000,000 1,034,000,000 949,000,000 1,103,000,000 905,000,000 802,000,000 799,000,000 717,000,000 606,000,000 854,000,000 759,000,000 649,000,000 867,000,000 828,000,000 681,000,000    
  other accrued liabilities5,656,000,000 5,600,000,000 5,143,000,000 5,427,000,000 5,071,000,000 5,220,000,000 5,422,000,000 5,347,000,000 5,334,000,000 5,758,000,000 5,845,000,000 5,475,000,000 5,400,000,000 5,577,000,000 5,181,000,000 5,264,000,000 5,354,000,000 5,247,000,000 5,165,000,000 4,659,000,000 4,206,000,000 4,408,000,000 4,035,000,000 4,112,000,000 3,961,000,000 4,130,000,000 3,807,000,000 3,887,000,000 4,144,000,000 3,617,000,000 3,357,000,000 3,506,000,000 2,715,000,000 2,931,000,000 3,118,000,000 3,294,000,000 3,288,000,000 3,380,000,000 2,875,000,000 3,247,000,000 3,401,000,000 5,677,368,000   
  dividends payable1,030,000,000 1,032,000,000 1,024,000,000 956,000,000 959,000,000 959,000,000 955,000,000 886,000,000 886,000,000 888,000,000 887,000,000 820,000,000 824,000,000 824,000,000 831,000,000 797,000,000 799,000,000 801,000,000 798,000,000 639,000,000 637,000,000 637,000,000 635,000,000 567,000,000 566,000,000 566,000,000 493,000,000 492,000,000 492,000,000 462,000,000 461,000,000 461,000,000 384,000,000 383,000,000 382,000,000 359,000,000 358,000,000 358,000,000 332,000,000 331,000,000 331,000,000    
  income taxes payable390,000,000 485,000,000 594,000,000 713,000,000 601,000,000 562,000,000 492,000,000 318,000,000 273,000,000 334,000,000 343,000,000 394,000,000 355,000,000 338,000,000 306,000,000 368,000,000 242,000,000 276,000,000 362,000,000 117,000,000 165,000,000 165,000,000 226,000,000 67,000,000 83,000,000 277,000,000 231,000,000 188,000,000 212,000,000 180,000,000 192,000,000 186,000,000 240,000,000 232,000,000 261,000,000 483,000,000 589,000,000 534,000,000 481,000,000 181,000,000 152,000,000 874,915,000 906,674,000 769,488,000 
  current portion of long-term debt507,000,000 506,000,000 1,500,000,000 2,154,000,000 1,615,000,000 2,010,000,000 1,080,000,000 1,051,000,000 2,284,000,000 2,285,000,000 2,251,000,000 1,117,000,000 5,000,000 4,000,000 754,000,000 754,000,000 755,000,000 756,000,000 7,000,000 6,000,000 1,290,000,000 1,264,000,000 1,277,000,000 1,254,000,000 8,000,000 8,000,000 4,063,000,000 506,000,000 507,000,000 504,000,000 3,000,000 3,000,000 4,000,000 4,000,000 3,000,000 32,000,000 32,000,000 51,000,000 206,000,000 9,000,000 8,000,000 2,218,542,000 2,217,419,000 718,093,000 
  total current liabilities13,439,000,000 13,004,000,000 14,157,000,000 14,902,000,000 13,760,000,000 14,021,000,000 13,841,000,000 13,042,000,000 14,350,000,000 14,530,000,000 15,489,000,000 13,365,000,000 12,392,000,000 12,647,000,000 13,105,000,000 12,867,000,000 12,614,000,000 12,462,000,000 11,907,000,000 10,257,000,000 10,959,000,000 10,808,000,000 10,863,000,000 10,491,000,000 9,062,000,000 9,113,000,000 12,776,000,000 8,951,000,000 9,010,000,000 7,935,000,000 6,803,000,000 6,646,000,000 8,321,000,000 8,673,000,000 8,393,000,000 8,755,000,000 9,185,000,000 9,206,000,000 10,823,000,000 9,853,000,000 10,186,000,000 15,583,871,000 14,689,260,000 15,183,485,000 
  long-term debt12,930,000,000 12,736,000,000 12,625,000,000 12,825,000,000 13,139,000,000 12,576,000,000 13,599,000,000 14,477,000,000 14,562,000,000 14,615,000,000 14,522,000,000 15,297,000,000 16,755,000,000 17,086,000,000 17,296,000,000 17,446,000,000 17,547,000,000 17,489,000,000 18,527,000,000 18,349,000,000 18,184,000,000 16,804,000,000 16,661,000,000 17,639,000,000 18,982,000,000 18,845,000,000 19,284,000,000 19,823,000,000 21,154,000,000 23,310,000,000 23,810,000,000 23,764,000,000 5,975,000,000 6,016,000,000 5,977,000,000 5,953,000,000 5,862,000,000 5,931,000,000 3,719,000,000 3,403,000,000 3,387,000,000 12,910,681,000 12,612,655,000 10,878,649,000 
  post-employment obligations, deferred income taxes and other long-term liabilities6,801,000,000 6,644,000,000  6,601,000,000 6,558,000,000 6,827,000,000  6,877,000,000 7,038,000,000 7,417,000,000  8,255,000,000 8,339,000,000 8,645,000,000  8,844,000,000 9,079,000,000 9,046,000,000  8,842,000,000 8,835,000,000 8,738,000,000  8,390,000,000 8,489,000,000 8,523,000,000 8,679,000,000 8,867,000,000 9,143,000,000 8,785,000,000 8,750,000,000 8,930,000,000 4,245,000,000 4,347,000,000 4,425,000,000 5,798,000,000 5,952,000,000 5,970,000,000 4,883,000,000 4,514,000,000 4,599,000,000   6,284,148,000 
  commitments and contingencies                                            
  shareholders’ investment:                                            
  preferred shares, one dollar par value authorized — 1,000,000 shares, none issued                                            
  common shares, without par value authorized — 2,400,000,000 shares issued at stated capital amount — shares: 2025: 1,996,448,469; 2024: 1,991,472,63025,284,000,000                                            
  common shares held in treasury, at cost — shares: 2025: 255,988,730; 2024: 259,774,639-16,610,000,000                                            
  earnings employed in the business48,467,000,000 47,715,000,000 47,261,000,000 39,056,000,000 38,354,000,000 38,011,000,000 37,554,000,000 36,920,000,000 36,355,000,000 35,868,000,000 35,257,000,000 35,115,000,000 34,487,000,000 33,295,000,000 31,528,000,000 30,376,000,000 29,053,000,000 28,669,000,000 27,627,000,000 26,266,000,000 25,669,000,000 25,786,000,000 25,847,000,000 25,440,000,000 25,045,000,000 24,613,000,000 24,144,000,000 24,080,000,000 23,856,000,000 25,320,000,000 25,202,000,000 25,387,000,000 25,162,000,000 25,884,000,000 25,654,000,000 25,375,000,000 25,162,000,000 24,740,000,000 22,335,000,000 22,137,000,000 22,005,000,000 18,181,133,000 17,978,462,000 17,367,857,000 
  accumulated other comprehensive income-6,576,000,000 -7,417,000,000 -7,906,000,000 -7,804,000,000 -8,135,000,000 -8,166,000,000 -7,839,000,000 -8,480,000,000 -8,071,000,000 -8,039,000,000 -8,051,000,000 -9,445,000,000 -8,706,000,000 -8,474,000,000 -8,374,000,000 -9,240,000,000 -9,066,000,000 -9,285,000,000 -8,946,000,000 -9,044,000,000 -9,080,000,000 -9,386,000,000 -8,465,000,000 -7,763,000,000 -7,365,000,000                    
  total abbott shareholders’ investment50,565,000,000 48,811,000,000 47,664,000,000 39,796,000,000 39,318,000,000 38,810,000,000 38,603,000,000 37,481,000,000 37,174,000,000 37,010,000,000 36,686,000,000 35,675,000,000 36,490,000,000 35,399,000,000 35,802,000,000 34,422,000,000 33,800,000,000 33,562,000,000 32,784,000,000 31,386,000,000 30,578,000,000 30,218,000,000 31,088,000,000 31,817,000,000 31,686,000,000 30,925,000,000 30,705,000,000 30,577,000,000 31,399,000,000 32,032,000,000 31,602,000,000 31,362,000,000 20,776,000,000 20,675,000,000 20,722,000,000 21,111,000,000 23,008,000,000 21,874,000,000 22,888,000,000 23,602,000,000 23,390,000,000 21,403,932,000 19,911,709,000 20,860,099,000 
  noncontrolling interests in subsidiaries264,000,000 253,000,000 237,000,000 232,000,000 242,000,000 233,000,000 224,000,000 213,000,000 230,000,000 222,000,000 219,000,000 209,000,000 226,000,000 230,000,000 222,000,000 216,000,000 229,000,000 226,000,000 219,000,000 209,000,000 220,000,000 209,000,000 213,000,000 202,000,000 208,000,000 204,000,000 193,000,000 197,000,000 202,000,000 186,000,000 186,000,000 185,000,000 120,000,000 120,000,000 120,000,000 108,000,000 118,000,000 114,000,000 105,000,000 102,000,000 99,000,000 78,792,000 82,925,000 152,241,000 
  total shareholders’ investment50,829,000,000 49,064,000,000 47,901,000,000 40,028,000,000 39,560,000,000 39,043,000,000 38,827,000,000 37,694,000,000 37,404,000,000 37,232,000,000 36,905,000,000 35,884,000,000 36,716,000,000 35,629,000,000 36,024,000,000 34,638,000,000 34,029,000,000 33,788,000,000 33,003,000,000 31,595,000,000 30,798,000,000 30,427,000,000 31,301,000,000 32,019,000,000 31,894,000,000 31,129,000,000 30,898,000,000 30,774,000,000 31,601,000,000 32,218,000,000 31,788,000,000 31,547,000,000 20,896,000,000 20,795,000,000 20,842,000,000 21,219,000,000 23,126,000,000 21,988,000,000 22,993,000,000 23,704,000,000 23,489,000,000    
  trade receivables, less allowances of 449 in 2025 and 439 in 2024 7,327,000,000                                           
  common shares, without par value authorized — 2,400,000,000 shares issued at stated capital amount — shares: 2025: 1,995,858,606; 2024: 1,991,472,630 25,125,000,000                                           
  common shares held in treasury, at cost — shares: 2025: 256,021,416; 2024: 259,774,639 -16,612,000,000                                           
  investments, primarily bank time deposits and u.s. treasury bills  351,000,000    383,000,000    288,000,000    450,000,000    310,000,000    280,000,000                1,264,000,000 3,492,000,000 4,987,000,000    
  trade receivables, less allowances of — 2024: 439; 2023: 444  6,925,000,000                                          
  other prepaid expenses and receivables  2,570,000,000    2,256,000,000    2,663,000,000    2,346,000,000    1,867,000,000    1,786,000,000                      
  property and equipment, at cost:                                            
  land  528,000,000    529,000,000    511,000,000    525,000,000    538,000,000    519,000,000                      
  buildings  4,207,000,000    4,161,000,000    4,053,000,000    4,007,000,000    4,014,000,000    3,702,000,000                      
  equipment  15,517,000,000    15,179,000,000    14,164,000,000    13,528,000,000    12,884,000,000    11,468,000,000                      
  construction in progress  2,488,000,000    2,064,000,000    1,484,000,000    1,304,000,000    1,357,000,000    1,110,000,000                      
  post-employment obligations and other long-term liabilities  6,731,000,000    6,947,000,000    7,522,000,000    8,771,000,000    9,111,000,000    9,062,000,000                   7,396,344,000 6,084,853,000  
  common shares, without par value authorized — 2,400,000,000 shares issued at stated capital amount — shares: 2024: 1,991,472,630; 2023: 1,987,883,852  25,153,000,000                                          
  common shares held in treasury, at cost — shares: 2024: 259,774,639; 2023: 253,807,494  -16,844,000,000                                          
  trade receivables, less allowances of 456 in 2024 and 444 in 2023   7,051,000,000                                         
  common shares, without par value authorized — 2,400,000,000 shares issued at stated capital amount — shares: 2024: 1,991,051,414; 2023: 1,987,883,852   25,020,000,000                                         
  common shares held in treasury, at cost — shares: 2024: 256,595,476; 2023: 253,807,494   -16,476,000,000                                         
  trade receivables, less allowances of 441 in 2024 and 444 in 2023    6,854,000,000                                        
  common shares, without par value authorized — 2,400,000,000 shares issued at stated capital amount — shares: 2024: 1,990,029,292; 2023: 1,987,883,852    24,858,000,000                                        
  common shares held in treasury, at cost — shares: 2024: 250,131,563; 2023: 253,807,494    -15,759,000,000                                        
  trade receivables, less allowances of 439 in 2024 and 444 in 2023     6,605,000,000                                       
  common shares, without par value authorized — 2,400,000,000 shares issued at stated capital amount — shares: 2024: 1,989,789,999; 2023: 1,987,883,852     24,726,000,000                                       
  common shares held in treasury, at cost — shares: 2024: 250,155,515; 2023: 253,807,494     -15,761,000,000                                       
  trade receivables, less allowances of — 2023: 444; 2022: 500      6,565,000,000                                      
  common shares, without par value authorized — 2,400,000,000 shares issued at stated capital amount — shares: 2023: 1,987,883,852; 2022: 1,986,519,278      24,869,000,000                                      
  common shares held in treasury, at cost — shares: 2023: 253,807,494; 2022: 248,724,257      -15,981,000,000                                      
  trade receivables, less allowances of 472 in 2023 and 500 in 2022       6,499,000,000                                     
  common shares, without par value authorized — 2,400,000,000 shares issued at stated capital amount — shares: 2023: 1,987,305,154; 2022: 1,986,519,278       24,727,000,000                                     
  common shares held in treasury, at cost — shares: 2023: 251,246,618; 2022: 248,724,257       -15,686,000,000                                     
  trade receivables, less allowances of 485 in 2023 and 500 in 2022        6,172,000,000                                    
  common shares, without par value authorized — 2,400,000,000 shares issued at stated capital amount — shares: 2023: 1,987,181,491; 2022: 1,986,519,278        24,612,000,000                                    
  common shares held in treasury, at cost — shares: 2023: 251,823,511; 2022: 248,724,257        -15,722,000,000                                    
  trade receivables, less allowances of 503 in 2023 and 500 in 2022         6,020,000,000                                   
  common shares, without par value authorized — 2,400,000,000 shares issued at stated capital amount — shares: 2023: 1,986,904,170; 2022: 1,986,519,278         24,488,000,000                                   
  common shares held in treasury, at cost — shares: 2023: 247,957,371; 2022: 248,724,257         -15,307,000,000                                   
  trade receivables, less allowances of — 2022: 500; 2021: 519          6,218,000,000                                  
  common shares, without par value authorized — 2,400,000,000 shares issued at stated capital amount — shares: 2022: 1,986,519,278; 2021: 1,985,273,421          24,709,000,000                                  
  common shares held in treasury, at cost — shares: 2022: 248,724,257; 2021: 221,191,228          -15,229,000,000                                  
  trade receivables, less allowances of 520 in 2022 and 519 in 2021           6,408,000,000                                 
  common shares, without par value authorized — 2,400,000,000 shares issued at stated capital amount — shares: 2022: 1,985,919,440; 2021: 1,985,273,421           24,560,000,000                                 
  common shares held in treasury, at cost — shares: 2022: 242,345,663; 2021: 221,191,228           -14,555,000,000                                 
  trade receivables, less allowances of 572 in 2022 and 519 in 2021            7,199,000,000                                
  common shares, without par value authorized — 2,400,000,000 shares issued at stated capital amount — shares: 2022: 1,985,676,735; 2021: 1,985,273,421            24,429,000,000                                
  common shares held in treasury, at cost — shares: 2022: 234,456,992; 2021: 221,191,228            -13,720,000,000                                
  trade receivables, less allowances of 640 in 2022 and 519 in 2021             7,179,000,000                               
  ​             74,007,000,000 19,364,000,000 73,795,000,000 73,269,000,000 72,785,000,000 18,793,000,000 69,043,000,000 68,776,000,000 66,777,000,000 16,799,000,000 68,539,000,000 68,427,000,000                    
  common shares, without par value authorized — 2,400,000,000 shares issued at stated capital amount — shares: 2022: 1,985,525,053; 2021: 1,985,273,421             24,304,000,000                               
  common shares held in treasury, at cost — shares: 2022: 234,582,764; 2021: 221,191,228             -13,726,000,000                               
  trade receivables, less allowances of - 2021: 519; 2020: 460              6,487,000,000                              
  short-term borrowings               197,000,000 199,000,000 199,000,000 213,000,000 208,000,000 205,000,000 204,000,000 201,000,000 204,000,000 204,000,000 201,000,000 211,000,000 341,000,000 230,000,000 211,000,000 218,000,000 207,000,000 2,531,000,000 2,892,000,000 2,610,000,000 2,370,000,000 2,867,000,000 2,921,000,000 4,376,000,000 3,953,000,000 4,370,000,000 3,587,830,000 3,650,975,000 5,730,427,000 
  common shares, without par value authorized — 2,400,000,000 shares issued at stated capital amount — shares: 2021: 1,985,273,421; 2020: 1,981,156,896              24,470,000,000                              
  common shares held in treasury, at cost — shares: 2021: 221,191,228; 2020: 209,926,622              -11,822,000,000                              
  trade receivables, less allowances of 507 in 2021 and 460 in 2020               6,405,000,000                             
  common shares, without par value authorized — 2,400,000,000 shares issued at stated capital amount — shares: 2021: 1,983,103,854; 2020: 1,981,156,896               24,285,000,000                             
  common shares held in treasury, at cost — shares: 2021: 214,816,885; 2020: 209,926,622               -10,999,000,000                             
  trade receivables, less allowances of 498 in 2021 and 460 in 2020                6,113,000,000                            
  common shares, without par value authorized — 2,400,000,000 shares issued at stated capital amount — shares: 2021: 1,982,553,488; 2020: 1,981,156,896                24,153,000,000                            
  common shares held in treasury, at cost — shares: 2021: 209,736,139; 2020: 209,926,622                -10,340,000,000                            
  trade receivables, less allowances of 475 in 2021 and 460 in 2020                 6,096,000,000                           
  common shares, without par value authorized — 2,400,000,000 shares issued at stated capital amount — shares: 2021: 1,982,205,491; 2020: 1,981,156,896                 24,023,000,000                           
  common shares held in treasury, at cost — shares: 2021: 205,385,343; 2020: 209,926,622                 -9,845,000,000                           
  trade receivables, less allowances of — 2020: 460; 2019: 384                  6,414,000,000                          
  common shares, without par value authorized — 2,400,000,000 shares issued at stated capital amount — shares: 2020: 1,981,156,896; 2019: 1,976,855,085                  24,145,000,000                          
  common shares held in treasury, at cost — shares: 2020: 209,926,622; 2019: 214,351,838                  -10,042,000,000                          
  trade receivables, less allowances of 446 in 2020 and 384 in 2019                   5,649,000,000                         
  common shares, without par value authorized — 2,400,000,000 shares issued at stated capital amount — shares: 2020: 1,980,767,223; 2019: 1,976,855,085                   24,037,000,000                         
  common shares held in treasury, at cost — shares: 2020: 208,405,642; 2019: 214,351,838                   -9,873,000,000                         
  trade receivables, less allowances of 422 in 2020 and 384 in 2019                    5,140,000,000                        
  common shares, without par value authorized — 2,400,000,000 shares issued at stated capital amount — shares: 2020: 1,979,594,379; 2019: 1,976,855,085                    23,893,000,000                        
  common shares held in treasury, at cost — shares: 2020: 209,064,380; 2019: 214,351,838                    -9,904,000,000                        
  trade receivables, less allowances of 389 in 2020 and 384 in 2019                     5,292,000,000                       
  common shares, without par value authorized — 2,400,000,000 shares issued at stated capital amount — shares: 2020: 1,978,112,501 ; 2019: 1,976,855,085                     23,731,000,000                       
  common shares held in treasury, at cost — shares: 2020: 209,267,175 ; 2019: 214,351,838                     -9,913,000,000                       
  trade receivables, less allowances of — 2019: 384; 2018: 314                      5,425,000,000                      
  common shares, without par value authorized — 2,400,000,000 shares issued at stated capital amount — shares: 2019: 1,976,855,085; 2018: 1,971,189,465                      23,853,000,000                      
  common shares held in treasury, at cost — shares: 2019: 214,351,838; 2018: 215,570,043                      -10,147,000,000                      
  trade receivables, less allowances of 354 in 2019 and 314 in 2018                       5,450,000,000                     
  common shares, without par value authorized — 2,400,000,000 shares issued at stated capital amount — shares: 2019: 1,976,705,285; 2018: 1,971,189,465                       23,771,000,000                     
  common shares held in treasury, at cost — shares: 2019: 208,249,580; 2018: 215,570,043                       -9,631,000,000                     
  trade receivables, less allowances of 338 in 2019 and 314 in 2018                        5,548,000,000                    
  common shares, without par value authorized — 2,400,000,000 shares issued at stated capital amount - shares: 2019: 1,976,248,129 ; 2018: 1,971,189,465                        23,665,000,000                    
  common shares held in treasury, at cost — shares: 2019: 208,850,514 ; 2018: 215,570,043                        -9,659,000,000                    
  trade receivables, less allowances of 331 in 2019 and 314 in 2018                         5,345,000,000                   
  common shares, without par value authorized — 2,400,000,000 shares issued at stated capital amount — shares: 2019: 1,973,472,506; 2018: 1,971,189,465                         23,461,000,000                   
  common shares held in treasury, at cost — shares: 2019: 209,291,244; 2018: 215,570,043                                            
  common shares:                                            
  balance at january 1                         24,560,000,000                   
  shares: 2019: 1,971,189,465; 2018: 1,965,908,188                         23,512,000,000                   
  issued under incentive stock programs                                            
  shares: 2019: 2,283,041; 2018: 3,422,819                         76,000,000                   
  share-based compensation                         237,000,000 396,000,000 313,000,000 212,000,000 338,000,000 263,000,000 171,000,000 263,000,000 214,000,000 152,000,000 249,000,000 205,000,000 148,000,000 208,000,000 168,000,000 119,000,000    
  issuance of restricted stock awards                                            
  balance at march 31                         24,613,000,000                   
  shares: 2019: 1,973,472,506; 2018: 1,969,331,007                         23,461,000,000                   
  common shares held in treasury:                                            
  shares: 2019: 215,570,043; 2018: 222,305,719                         -9,962,000,000                   
  shares: 2019: 6,544,927; 2018: 6,402,695                         303,000,000                   
  purchased                                            
  shares: 2019: 266,128; 2018: 240,217                                            
  shares: 2019: 209,291,244; 2018: 216,143,241                         -9,679,000,000                   
  earnings employed in the business:                                            
  impact of adoption of new accounting standards                                            
  net earnings                         672,000,000 1,714,000,000 1,151,000,000 418,000,000 1,305,000,000 702,000,000 419,000,000 602,000,000 931,000,000 316,000,000 3,656,000,000 3,076,000,000 2,292,000,000 1,380,000,000 841,000,000 375,000,000    
  cash dividends declared on common shares                                            
  effect of common and treasury share transactions                                            
  accumulated other comprehensive income:                                            
  impact of adoption of new accounting standard                                            
  other comprehensive income                         116,000,000                   
  noncontrolling interests in subsidiaries:                                            
  noncontrolling interests’ share of income, business combinations, net of distributions and share repurchases                         6,000,000                   
  trade receivables, less allowances of 326 in 2018 and 294 in 2017                          5,271,000,000                  
  current assets held for disposition                          12,000,000 17,000,000 20,000,000    552,000,000 66,000,000 76,000,000 139,000,000 93,000,000 173,000,000 1,100,000,000 252,000,000 249,000,000    
  non-current assets held for disposition                          19,000,000 121,000,000 120,000,000 57,000,000   2,779,000,000 2,000,000 2,000,000 2,000,000 2,000,000 3,000,000 2,043,000,000 52,000,000 53,000,000    
  common shares, without par value authorized — 2,400,000,000 shares issued at stated capital amount — shares: 2018: 1,970,590,472; 2017: 1,965,908,188                          23,428,000,000                  
  common shares held in treasury, at cost — shares: 2018: 214,257,440; 2017: 222,305,719                                            
  cash flow from (used in) operating activities:                                            
  adjustments to reconcile net earnings to net cash from operating activities -                                            
  depreciation                          825,000,000 556,000,000 268,000,000 763,000,000 508,000,000 252,000,000 605,000,000 405,000,000 203,000,000 648,000,000 416,000,000 215,000,000 689,000,000 463,000,000 224,000,000    
  amortization of intangible assets                          1,690,000,000 1,146,000,000 584,000,000 1,415,000,000 914,000,000 522,000,000 429,000,000 289,000,000 144,000,000          
  amortization of inventory step-up                          32,000,000 32,000,000 32,000,000 840,000,000 822,000,000 392,000,000             
  gain on sale of businesses                                            
  trade receivables                               30,000,000         82,000,000    
  inventories                             39,000,000               
  other                          608,000,000 30,000,000 42,000,000 562,000,000 50,000,000 101,000,000 34,000,000 28,000,000  535,000,000 301,000,000 230,000,000 72,000,000 27,000,000 27,000,000    
  net cash from operating activities                          4,535,000,000 2,352,000,000 1,108,000,000 3,930,000,000 1,925,000,000 574,000,000 2,033,000,000 816,000,000  2,138,000,000 943,000,000 2,000,000 2,437,000,000 1,236,000,000 336,000,000    
  cash flow from (used in) investing activities:                                            
  acquisitions of property and equipment                                            
  acquisitions of businesses and technologies, net of cash acquired                                            
  proceeds from business dispositions                          48,000,000 48,000,000  5,442,000,000 5,471,000,000              
  proceeds from the sale of mylan n.v. shares                             1,977,000,000 1,924,000,000 1,685,000,000    2,290,000,000         
  sales (purchases) of other investment securities                                            
  net cash (used in) investing activities                                            
  cash flow from (used in) financing activities:                                            
  net borrowings (repayments) of short-term debt and other                          22,000,000 140,000,000                 
  proceeds from issuance of long-term debt                          4,011,000,000                  
  repayments of long-term debt                                            
  payment of debt issuance costs                                            
  payment of contingent consideration                                            
  purchases of common shares                                            
  proceeds from stock options exercised                          244,000,000 170,000,000 137,000,000 275,000,000 186,000,000 129,000,000             
  dividends paid                                            
  net cash (used in) financing activities                                            
  effect of exchange rate changes on cash and cash equivalents                            35,000,000 97,000,000 73,000,000 65,000,000             
  net decrease in cash and cash equivalents                                            
  cash and cash equivalents, beginning of year                          9,407,000,000 9,407,000,000 9,407,000,000 18,620,000,000 18,620,000,000 18,620,000,000 5,001,000,000 5,001,000,000 5,001,000,000 4,063,000,000 4,063,000,000 4,063,000,000 3,475,000,000 3,475,000,000 3,475,000,000    
  cash and cash equivalents, end of period                          7,369,000,000 3,065,000,000 3,857,000,000 11,012,000,000 9,675,000,000 8,706,000,000 2,500,000,000 2,578,000,000 3,334,000,000 3,132,000,000 4,048,000,000 3,226,000,000 3,613,000,000 3,570,000,000 2,060,000,000    
  trade receivables, less allowances of 319 in 2018 and 294 in 2017                           5,192,000,000                 
  common shares, without par value authorized — 2,400,000,000 shares issued at stated capital amount — shares: 2018: 1,969,575,366; 2017: 1,965,908,188                           23,317,000,000                 
  common shares held in treasury, at cost — shares: 2018: 215,256,082; 2017: 222,305,719                                            
  trade receivables, less allowances of 321 in 2018 and 294 in 2017                            5,356,000,000                
  common shares, without par value authorized - 2,400,000,000 shares issued at stated capital amount - shares: 2018: 1,969,331,007; 2017: 1,965,908,188                            23,223,000,000                
  common shares held in treasury, at cost - shares: 2018: 216,143,241; 2017: 222,305,719                                            
  adjustments to reconcile earnings to net cash from operating activities -                                            
  proceeds from business disposition                               5,472,000,000 25,000,000 25,000,000 25,000,000 230,000,000 230,000,000 230,000,000       
  sales (purchases) of investment securities                                  446,000,000    3,358,000,000 1,119,000,000     
  net cash from investing activities                                  226,000,000  37,000,000   633,000,000     
  net proceeds (repayments of) short-term debt and other                            6,000,000                
  net cash from financing activities                                            
  trade receivables, less allowances of 279 in 2017 and 250 in 2016                             4,800,000,000               
  current liabilities held for disposition                                597,000,000 361,000,000 360,000,000 356,000,000 292,000,000 301,000,000 721,000,000 242,000,000 169,000,000    
  non-current liabilities held for disposition                                60,000,000      96,000,000 1,000,000 1,000,000    
  common shares, without par value authorized — 2,400,000,000 shares issued at stated capital amount — shares: 2017: 1,964,324,771; 2016: 1,707,475,455                             23,118,000,000               
  common shares held in treasury, at cost — shares: 2017: 223,724,084; 2016: 234,606,250                                            
  impact of currency devaluation                                481,000,000 477,000,000 477,000,000          
  mylan n.v. equity investment adjustment                                947,000,000            
  net (repayments of) short-term debt and other                                            
  trade receivables, less allowances of 265 in 2017 and 250 in 2016                              4,633,000,000              
  common shares, without par value authorized — 2,400,000,000 shares issued at stated capital amount — shares: 2017: 1,962,732,172; 2016: 1,707,475,455                              23,012,000,000              
  common shares held in treasury, at cost — shares: 2017: 225,288,908; 2016: 234,606,250                                            
  trade receivables, less allowances of 263 in 2017 and 250 in 2016                               4,510,000,000             
  common shares, without par value authorized - 2,400,000,000 shares issued at stated capital amount - shares: 2017: 1,960,925,194; 2016: 1,707,475,455                               22,886,000,000             
  common shares held in treasury, at cost - shares: 2017: 225,653,140; 2016: 234,606,250                                            
  trade receivables, less allowances of 284 in 2016 and 337 in 2015                                3,320,000,000            
  common shares, without par value authorized - 2,400,000,000 shares issued at stated capital amount - shares: 2016: 1,706,957,661; 2015: 1,702,017,390                                12,939,000,000            
  common shares held in treasury, at cost — shares: 2016: 234,648,138; 2015: 229,352,338                                            
  gain on sale of discontinued operations                                            
  gain on sale of mylan n.v. shares                                            
  net (repayments of) proceeds from issuance of short-term debt and other                                            
  proceeds from the issuance of long-term debt                                   2,485,000,000 2,485,000,000 2,485,000,000       
  proceeds from stock options exercised, including income tax benefit                                206,000,000 130,000,000 87,000,000 263,000,000 213,000,000 156,000,000 290,000,000 226,000,000 170,000,000    
  trade receivables, less allowances of 347 in 2016 and 337 in 2015                                 3,567,000,000           
  common shares, without par value authorized - 2,400,000,000 shares issued at stated capital amount - shares: 2016: 1,705,266,590; 2015: 1,702,017,390                                 12,835,000,000           
  common shares held in treasury, at cost — shares: 2016: 235,271,175; 2015: 229,352,338                                            
  gain on sale of mylan shares                                            
  proceeds from the sale of mylan shares                                    2,290,000,000        
  net cash (used in) from investing activities                                            
  trade receivables, less allowances of 350 in 2016 and 337 in 2015                                  3,430,000,000          
  common shares, without par value authorized - 2,400,000,000 shares issued at stated capital amount - shares: 2016: 1,704,495,344; 2015: 1,702,017,390                                  12,744,000,000          
  common shares held in treasury, at cost - shares: 2016: 235,343,311; 2015: 229,352,338                                            
  net cash (used in) from operating activities                                            
  trade receivables, less allowances of 358 in 2015 and 310 in 2014                                   3,460,000,000         
  prepaid expenses, deferred income taxes, and other receivables                                   3,523,000,000 3,573,000,000 3,859,000,000 4,173,000,000 4,065,000,000 3,977,000,000  4,164,602,000 4,067,462,000 
  common shares, without par value authorized - 2,400,000,000 shares issued at stated capital amount - shares: 2015: 1,700,525,346; 2014: 1,694,929,949                                   12,641,000,000         
  common shares held in treasury, at cost — shares: 2015: 208,805,455; 2014: 186,894,515                                            
  amortization of intangibles                                   458,000,000 307,000,000 156,000,000 464,000,000 335,000,000 174,000,000    
  (purchases) sales of other investment securities                                            
  net (repayments of ) proceeds from issuance of short-term debt and other                                            
  contingent and other consideration payments related to business acquisitions                                            
  net increase in cash and cash equivalents                                      138,000,000 95,000,000     
  trade receivables, less allowances of 362 in 2015 and 310 in 2014                                    3,553,000,000        
  common shares, without par value authorized - 2,400,000,000 shares issued at stated capital amount - shares: 2015: 1,699,703,688; 2014: 1,694,929,949                                    12,566,000,000        
  common shares held in treasury, at cost - shares: 2015: 209,262,223; 2014: 186,894,515                                            
  trade receivables, less allowances of 317 in 2015 and 310 in 2014                                     3,481,000,000       
  common shares, without par value authorized - 2,400,000,000 shares issued at stated capital amount - shares: 2015: 1,698,124,396; 2014: 1,694,929,949                                     12,462,000,000       
  common shares held in treasury, at cost - shares: 2015: 209,367,078; 2014: 186,894,515                                            
  purchases of investment securities                                            
  net (repayments of) proceeds from short-term debt and other                                            
  trade receivables, less allowances of 332 in 2014 and 312 in 2013                                      3,618,000,000      
  common shares, without par value authorized - 2,400,000,000 shares issued at stated capital amount - shares: 2014: 1,692,708,693; 2013: 1,685,827,096                                      12,207,000,000      
  common shares held in treasury, at cost - shares: 2014: 186,918,107; 2013: 137,728,810                                            
  acquisitions of business and technology                                            
  proceeds from issuance of short-term debt and other                                      1,269,000,000 872,000,000 1,213,000,000    
  transfer of cash and cash equivalents to abbvie inc.                                            
  trade receivables, less allowances of 354 in 2014 and 312 in 2013                                       4,056,000,000     
  common shares, without par value authorized - 2,400,000,000 shares issued at stated capital amount - shares: 2014: 1,691,263,815; 2013: 1,685,827,096                                       12,126,000,000     
  common shares held in treasury, at cost - shares: 2014: 187,564,782; 2013: 137,728,810                                            
  trade receivables, less allowances of 324 in 2014 and 312 in 2013                                        3,883,000,000    
  common shares, without par value authorized - 2,400,000,000 shares                                            
  issued at stated capital amount - shares: 2014: 1,689,594,829; 2013: 1,685,827,096                                        12,032,000,000    
  common shares held in treasury, at cost - shares: 2014: 187,656,291; 2013: 137,728,810                                            
  investments, primarily time deposits and certificates of deposit                                         31,806,000 51,076,000 255,253,000 
  restricted funds, primarily u.s. treasury bills                                         1,871,807,000 1,870,936,000 1,870,000,000 
  trade receivables, less allowances of 330,469 in 2010 and 311,546 in 2009                                         6,248,908,000   
  prepaid expenses, deferred income taxes and other receivables                                         4,167,996,000   
  salaries, wages and commissions and dividends payable                                         1,693,496,000   
  common shares, without par value authorized — 2,400,000,000 shares issued at stated capital amount - shares: 2010: 1,618,549,245; 2009: 1,612,683,987                                         8,624,344,000   
  common shares held in treasury, at cost — shares: 2010: 72,733,280; 2009: 61,516,398                                            
  total equity                                         21,482,724,000 19,994,634,000 21,012,340,000 
  trade receivables, less allowances of 304,348 in 2010 and 311,546 in 2009                                          6,338,350,000  
  salaries, dividends payable, and other accruals                                          6,298,586,000 6,301,954,000 
  preferred shares, one dollar par value authorized - 1,000,000 shares, none issued                                            
  issued at stated capital amount -                                            
  shares: 2010: 1,617,202,849; 2009: 1,612,683,987                                          8,504,865,000  
  common shares held in treasury, at cost -                                            
  shares: 2010: 73,174,127; 2009: 61,516,398                                            
  trade receivables, less allowances of 315,873 in 2010 and 311,546 in 2009                                           6,520,222,000 
  shares: 2010: 1,616,801,616; 2009: 1,612,683,987                                           8,413,595,000 
  shares: 2010: 73,236,557; 2009: 61,516,398                                            

We provide you with 20 years of balance sheets for Abbott Laboratories stock, allowing you to gain comprehensive visibility into the fundamentals of the company. Our detailed breakdowns include key financial metrics such as asset and liabilities, payables and receivables, long debts and short debts, cash and inventories, expenses and profits. This in-depth information is essential for making informed investment decisions and understanding the financial health and performance of Abbott Laboratories. Explore the full financial landscape of Abbott Laboratories stock with our expertly curated balance sheets.

The information provided in this report about Abbott Laboratories stock is taken from www.sec.gov and many other data providers. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.